Japanese Marine and Shipping Stock News

TSE:3626
TSE:3626IT

Why TIS (TSE:3626) Is Up After Raising Earnings Guidance and Boosting Dividend

On October 31, 2025, TIS Inc. raised its consolidated earnings guidance for the fiscal year ending March 31, 2026, projecting net sales of ¥588.00 billion and operating profit of ¥75.00 billion, alongside announcing a second-quarter dividend increase to ¥38 per share, payable December 5, 2025. This combination of upward earnings revision and a higher dividend signals management’s increased optimism about the company's outlook and operational momentum. We’ll examine how the raised full-year...
TSE:4307
TSE:4307IT

A Look at Nomura Research Institute’s (TSE:4307) Valuation Following New Earnings Guidance and Dividend Hike

Nomura Research Institute (TSE:4307) has just released its earnings guidance for the fiscal year ending March 2026, along with plans to raise both its quarterly and full-year dividends compared to last year. This move is drawing fresh attention from investors who closely monitor profit outlooks and shareholder rewards. See our latest analysis for Nomura Research Institute. Nomura Research Institute’s recent guidance and dividend boost landed as the stock was already building impressive...
TSE:4536
TSE:4536Pharmaceuticals

MHRA Approval of Ryjunea® Could Be a Game Changer for Santen Pharmaceutical (TSE:4536)

In the past week, Santen Pharmaceutical announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) approved Ryjunea® (low-dose atropine 0.1 mg/ml) as the first licensed treatment to slow the progression of myopia in children, following earlier European Commission approval and launches in Europe. This milestone offers Santen a new opportunity to address the rising prevalence of childhood myopia in the UK and further strengthens its international presence in paediatric...